Earnings History Data for Harrow, Inc. (HROW) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Harrow, Inc.
Harrow Health Inc. owns a portfolio of healthcare businesses, including an ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals and Radley Pharmaceuticals as subsidiaries. Harrow Health Inc., formerly known as Imprimis Pharmaceuticals Inc., is based in San Diego, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19-03-2024 | PM | HROW | Harrow, Inc. | 368.39 | -0.27 | 0.00 | 0.07 | Harrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5M [3/20/2024 1:11 AM] |
10.51 | -0.14 (-1.31%) |
9.50 | -1.15 (-10.80%) |
7.60 - 28.25 | 2,300,960 | 350,000 | 296,277 | ||
| 13-11-2023 | AH | HROW | Harrow, Inc. | 450.18 | -0.09 | 0.03 | -0.06 | Harrow Health GAAP EPS of -$0.13 misses by $0.17, revenue of $34.3M misses by $3.28M [11/13/2023 4:08 PM] |
8.22 | -4.61 (-35.93%) |
9.69 | -3.14 (-24.47%) |
7.60 - 28.25 | 6,754,293 | 660,000 | 171,279 | ||
| 09-08-2023 | AH | HROW | Harrow Health, Inc. | 629.25 | -0.02 | 0.00 | 0.01 | Harrow Health Non-GAAP EPS of -$0.02, revenue of $33.5M beats by $2.46M [8/9/2023 4:20 PM] |
16.76 | -3.04 (-15.35%) |
20.05 | 0.25 (1.26%) |
7.12 - 28.25 | 1,796,533 | 330,000 | 29,620 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
HROW | Harrow Health, Inc. | 841.49 | -0.03 | -0.06 | 0.03 | Harrow Health Non-GAAP EPS of -$0.03, revenue of $26.1M beats by $1.11M [5/11/2023 4:04 PM] |
21.91 | -5.16 (-19.04%) |
24.80 | -2.27 (-8.39%) |
5.40 - 28.25 | 2,505,354 | 350,000 | 5,199 | |
| 23-03-2023 | AH | 4:05 PM ET (Mar 23) |
HROW | Harrow Health, Inc. | 489.15 | 0.07 | -0.15 | -0.01 | Harrow Health Non-GAAP EPS of $0.07, revenue of $20.3M misses by $1.43M [3/23/2023 4:09 PM] |
18.42 | 1.17 (6.78%) |
18.00 | 0.75 (4.35%) |
5.40 - 20.31 | 373,854 | 440,000 | 4,553 | |
| 14-11-2022 | AH | 4:00 PM ET (Nov 14) |
HROW | Harrow Health, Inc. | 304.81 | -0.06 | 0.02 | 0.05 | Harrow Health GAAP EPS of -$0.24 misses by $0.23, revenue of $22.8M misses by $0.34M [11/14/2022 4:11 PM] |
11.04 | -0.56 (-4.81%) |
0.0 | 0.0 (0.00%) |
5.40 - 13.29 | 275,339 | 150,000 | 0 | |
| 09-08-2022 | AH | 4:00 PM ET (Aug 9) |
HROW | Harrow Health, Inc. | 190.84 | 0.01 | 0.00 | -0.11 | 7.58 | 0.62 (8.91%) |
0.0 | 0.0 (0.00%) |
5.40 - 12.99 | 109,965 | 40,000 | 0 | ||
| 05-05-2022 | AH | 4:00 PM ET (May 5) |
HROW | Harrow Health, Inc. | 185.16 | 0.03 | -0.04 | 0.11 | Harrow Health Non-GAAP EPS of $0.03 beats by $0.07, revenue of $22.12M beats by $2.64M [5/5/2022 5:03 PM] |
6.88 | 0.46 (7.17%) |
6.61 | 0.0 (0.00%) |
6.25 - 12.99 | 57,950 | 150,000 | 151 | |
|
||||||||||||||||||
| 10-03-2022 | AH | 4:00 PM ET (Mar 10) |
HROW | Harrow Health, Inc. | 193.16 | -0.01 | 0.08 | 0.07 | Harrow Health GAAP EPS of -$0.27 misses by $0.23, revenue of $20.2M beats by $0.84M [3/10/2022 4:02 PM] |
7.30 | 0.23 (3.22%) |
6.75 | -0.32 (-4.53%) |
6.00 - 12.99 | 109,758 | 60,000 | 37,651 | |
|
||||||||||||||||||
| 09-11-2021 | AH | 4:00 PM ET (Nov 9) |
HROW | Harrow Health, Inc. | 322.73 | 0.05 | 0.03 | 0.04 | Harrow Health EPS misses by $0.28, beats on revenue [11/9/2021 4:53 PM] |
10.93 | -0.55 (-4.79%) |
0.0 | 0.0 (0.00%) |
5.13 - 12.99 | 299,072 | 170,000 | 0 | |
| 10-08-2021 | AH | 4:00 PM ET (Aug 10) |
HROW | Harrow Health, Inc. | 243.49 | -0.11 | 0.04 | -0.13 | Harrow Health EPS misses by $0.10, beats on revenue [8/10/2021 4:17 PM] |
9.03 | 0.01 (0.11%) |
9.20 | 0.18 (2.00%) |
4.65 - 11.24 | 173,717 | 160,000 | 320 | |
| 11-05-2021 | AH | 4:00 PM ET (May 11) |
HROW | Harrow Health, Inc. | 217.18 | 0.11 | 0.04 | -0.05 | Harrow Health EPS beats by $0.05, beats on revenue [5/11/2021 4:02 PM] |
9.10 | 1.30 (16.67%) |
8.00 | 0.20 (2.56%) |
3.63 - 11.10 | 1,107,861 | 220,000 | 2,003 | |
| 08-03-2021 | AH | 4:00 PM ET (Mar 8) |
HROW | Harrow Health, Inc. | 197.47 | 0.07 | 0.00 | 0.10 | Harrow Health EPS beats by $0.02, beats on revenue [3/8/2021 4:04 PM] |
8.24 | 0.22 (2.68%) |
0.0 | 0.0 (0.00%) |
3.33 - 11.10 | 383,204 | 243,768 | 0 | |
| 09-11-2020 | AH | 4:00 PM ET (Nov 9) |
HROW | Harrow Health, Inc. | 125.68 | 0.04 | -0.11 | -0.29 | Harrow Health EPS of $0.32 [11/9/2020 4:41 PM] |
6.18 | 1.09 (21.41%) |
5.09 | 0.0 (0.00%) |
3.33 - 7.92 | 277,673 | 155,343 | 300 | |
|
|
||||||||||||||||||
| 10-08-2020 | AH | 4:00 PM ET (Aug 10) |
HROW | Harrow Health, Inc. | 147.31 | -0.13 | -0.21 | -0.09 | Harrow Health EPS beats by $0.09, beats on revenue [8/10/2020 4:08 PM] |
6.42 | 0.51 (8.63%) |
5.91 | 0.0 (0.00%) |
3.33 - 7.92 | 190,344 | 127,321 | 629 | |
|
|
||||||||||||||||||